Lista de obras -

5-Year Estimated Glomerular Filtration Rate in Patients with Hypoparathyroidism Treated with and Without rhPTH(1-84)

scientific article published on 01 August 2020

A direct role of collagen glycation in bone fracture

artículo científico publicado en 2015

Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice

artículo científico publicado en 2016

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial

artículo científico publicado en 2004

An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma

artículo científico publicado en 2007

Anabolic Agents for Osteoporosis : What is Their Likely Place in Therapy?

artículo científico publicado en 2006

Anabolic skeletal therapy for osteoporosis

artículo científico publicado en 2006

Arterial stiffness in mild primary hyperparathyroidism

artículo científico publicado en 2005

Asymptomatic primary hyperparathyroidism

artículo científico publicado en 2006

Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study

artículo científico publicado en 2006

Changes in Skeletal Microstructure Through Four Continuous Years of rhPTH(1-84) Therapy in Hypoparathyroidism

scientific article published on 10 March 2020

Circulating Sclerostin in Disorders of Parathyroid Gland Function ⬇️

artículo científico publicado el 21 de septiembre de 2011

Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence

artículo científico publicado en 2002

Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis

artículo científico publicado en 2006

Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis

artículo científico publicado en 2018

Correction: Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice

artículo científico publicado en 2016

Discrepant areal and volumetric bone density measurements in a young woman with idiopathic low bone mineral density.

artículo científico publicado en 2003

Dynamic and structural properties of the skeleton in hypoparathyroidism

artículo científico publicado en 2008

Editorial: HRPT2 in parathyroid cancer: a piece of the puzzle

artículo científico publicado en 2005

Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism

artículo científico publicado en 2016

Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus

artículo científico publicado en 2015

Glucose intolerance and primary hyperparathyroidism: an unresolved relationship ⬇️

artículo científico publicado el 1 de octubre de 2012

Human chorionic gonadotropin measurements in parathyroid carcinoma

artículo científico publicado en 2008

Hypoglycemia Secondary to Sulfonylurea Ingestion in a Patient with End Stage Renal Disease: Results from a 72-Hour Fast

artículo científico publicado en 2015

Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research

artículo científico publicado en 2011

Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement

artículo científico publicado en 2010

Idiopathic osteoporosis in premenopausal women

artículo científico publicado en 2004

In Vivo Precision of Digital Topological Skeletonization Based Individual Trabecula Segmentation (ITS) Analysis of Trabecular Microstructure at the Distal Radius and Tibia by HR-pQCT.

artículo científico publicado en 2015

Management of Hypoparathyroidism: Present and Future

artículo científico publicado en 2016

Mini-review: new therapeutic options in hypoparathyroidism ⬇️

artículo científico publicado el 7 de febrero de 2012

New anabolic therapies in osteoporosis

artículo científico publicado en 2002

New anabolic therapies in osteoporosis

scientific article published on 01 March 2003

Noninvasive Assessment of Skeletal Microstructure and Estimated Bone Strength in Hypoparathyroidism

artículo científico publicado en 2015

Nontraditional manifestations of primary hyperparathyroidism.

artículo científico publicado en 2013

Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation

artículo científico publicado en 2011

PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization

artículo científico publicado en 2015

PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism

artículo científico publicado en 2011

PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy

artículo científico publicado en 2014

PTH(1-84) replacement therapy for the treatment of hypoparathyroidism

artículo científico publicado en 2015

Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes

artículo científico publicado en 2013

Parathyroid carcinoma

article from 2008

Parathyroid hormone 1-84 alters circulating vascular endothelial growth factor levels in hypoparathyroidism

artículo científico publicado en 2014

Parathyroid hormone as an anabolic skeletal therapy

artículo científico publicado en 2005

Parathyroid hormone therapy for hypoparathyroidism

artículo científico publicado en 2014

Patient-specific bone modelling and remodelling simulation of hypoparathyroidism based on human iliac crest biopsies

artículo científico publicado en 2012

Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures.

artículo científico publicado en 2003

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop

artículo científico publicado en 2009

Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy

scientific article published on 01 July 2019

Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism

artículo científico publicado en 2003

Recent advances in understanding and managing hypoparathyroidism

scientific article published on 23 July 2020

Recovery of parathyroid hormone secretion and function in postoperative hypoparathyroidism: a case series

artículo científico publicado en 2013

Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy

artículo científico publicado en 2002

Skeletal Microstructure and Estimated Bone Strength Improve Following Parathyroidectomy in Primary Hyperparathyroidism

artículo científico publicado en 2017

Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism

artículo científico publicado en 2016

The Effects of Long-term Administration of rhPTH(1-84) in Hypoparathyroidism by Bone Histomorphometry.

artículo científico publicado en 2018

The anabolic effects of parathyroid hormone therapy

artículo científico publicado en 2003

The effect of PTH(1-84) on quality of life in hypoparathyroidism

artículo científico publicado en 2013

The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years

artículo científico publicado en 2008

The potential of parathyroid hormone as a therapy for osteoporosis.

artículo científico publicado en 2002

The use of parathyroid hormone in the treatment of osteoporosis

artículo científico publicado en 2006

Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety

artículo científico publicado en 2016

Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety

scientific article published on 01 November 2019

Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety

artículo científico publicado en 2012

Three dimensional cancellous bone structure in hypoparathyroidism

artículo científico publicado en 2009

Trabecular Bone Score in Obese and Non-obese Subjects with Primary Hyperparathyroidism Before and After Parathyroidectomy.

artículo científico publicado en 2018

Vascular calcification and osteoporosis--the nature of the nexus.

artículo científico publicado en 2004

Lista de obras de

5-Year Estimated Glomerular Filtration Rate in Patients with Hypoparathyroidism Treated with and Without rhPTH(1-84)

A direct role of collagen glycation in bone fracture

Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial

An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma

Anabolic Agents for Osteoporosis : What is Their Likely Place in Therapy?

Anabolic skeletal therapy for osteoporosis

Arterial stiffness in mild primary hyperparathyroidism

Asymptomatic primary hyperparathyroidism

Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study

Changes in Skeletal Microstructure Through Four Continuous Years of rhPTH(1-84) Therapy in Hypoparathyroidism

Circulating Sclerostin in Disorders of Parathyroid Gland Function ⬇️

Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence

Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis

Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis

Correction: Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice

Discrepant areal and volumetric bone density measurements in a young woman with idiopathic low bone mineral density.

Dynamic and structural properties of the skeleton in hypoparathyroidism

Editorial: HRPT2 in parathyroid cancer: a piece of the puzzle

Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism

Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus

Glucose intolerance and primary hyperparathyroidism: an unresolved relationship ⬇️

Human chorionic gonadotropin measurements in parathyroid carcinoma

Hypoglycemia Secondary to Sulfonylurea Ingestion in a Patient with End Stage Renal Disease: Results from a 72-Hour Fast

Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research

Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement

Idiopathic osteoporosis in premenopausal women

In Vivo Precision of Digital Topological Skeletonization Based Individual Trabecula Segmentation (ITS) Analysis of Trabecular Microstructure at the Distal Radius and Tibia by HR-pQCT.

Management of Hypoparathyroidism: Present and Future

Mini-review: new therapeutic options in hypoparathyroidism ⬇️

New anabolic therapies in osteoporosis

New anabolic therapies in osteoporosis

Noninvasive Assessment of Skeletal Microstructure and Estimated Bone Strength in Hypoparathyroidism

Nontraditional manifestations of primary hyperparathyroidism.

Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation

PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization

PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism

PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy

PTH(1-84) replacement therapy for the treatment of hypoparathyroidism

Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes

Parathyroid carcinoma

Parathyroid hormone 1-84 alters circulating vascular endothelial growth factor levels in hypoparathyroidism

Parathyroid hormone as an anabolic skeletal therapy

Parathyroid hormone therapy for hypoparathyroidism

Patient-specific bone modelling and remodelling simulation of hypoparathyroidism based on human iliac crest biopsies

Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures.

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop

Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy

Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism

Recent advances in understanding and managing hypoparathyroidism

Recovery of parathyroid hormone secretion and function in postoperative hypoparathyroidism: a case series

Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy

Skeletal Microstructure and Estimated Bone Strength Improve Following Parathyroidectomy in Primary Hyperparathyroidism

Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism

The Effects of Long-term Administration of rhPTH(1-84) in Hypoparathyroidism by Bone Histomorphometry.

The anabolic effects of parathyroid hormone therapy

The effect of PTH(1-84) on quality of life in hypoparathyroidism

The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years

The potential of parathyroid hormone as a therapy for osteoporosis.

The use of parathyroid hormone in the treatment of osteoporosis

Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety

Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety

Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety

Three dimensional cancellous bone structure in hypoparathyroidism

Trabecular Bone Score in Obese and Non-obese Subjects with Primary Hyperparathyroidism Before and After Parathyroidectomy.

Vascular calcification and osteoporosis--the nature of the nexus.